Literature DB >> 24003726

[Peptide bioregulators: the new class of geroprotectors. Message 2. Clinical studies results].

V Kh Khavinson, B I Kuznik, G A Ryzhak.   

Abstract

The review summarizes the results of long-term studies of the authors on the clinical efficacy of peptide bioregulators (Timalin, Thymogen, Vilon, Epithalamin, Prostatilen, Cortexin, Retinalamin) for the prevention of diseases and treatment of people of different age. Special attention is given to the analysis of the use of peptide bioregulators as geroprotectors.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24003726

Source DB:  PubMed          Journal:  Adv Gerontol        ISSN： 1561-9125


  3 in total

1.  Glu-Trp-ONa or its acylated analogue (R-Glu-Trp-ONa) administration enhances the wound healing in the model of chronic skin wounds in rabbits.

Authors:  Maxim A Shevtsov; Larisa V Smagina; Tatiana A Kudriavtceva; Sergey V Petlenko; Irina V Voronkina
Journal:  Drug Des Devel Ther       Date:  2015-03-20       Impact factor: 4.162

2.  AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism.

Authors:  Vladimir Khavinson; Francesca Diomede; Ekaterina Mironova; Natalia Linkova; Svetlana Trofimova; Oriana Trubiani; Sergio Caputi; Bruna Sinjari
Journal:  Molecules       Date:  2020-01-30       Impact factor: 4.411

Review 3.  Peptides: Prospects for Use in the Treatment of COVID-19.

Authors:  Vladimir Khavinson; Natalia Linkova; Anastasiia Dyatlova; Boris Kuznik; Roman Umnov
Journal:  Molecules       Date:  2020-09-24       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.